Predictive and sensitive biomarkers for thyroid dysfunctions during treatment with immune‐checkpoint inhibitors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Predictive and sensitive biomarkers for thyroid dysfunctions during treatment with immune‐checkpoint inhibitors

Published:2020-03-17 Issue:5 Volume:111 Page:1468-1477
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Kurimoto Chiaki¹,Inaba Hidefumi¹^ORCID,Ariyasu Hiroyuki¹,Iwakura Hiroshi¹,Ueda Yoko¹,Uraki Shinsuke¹,Takeshima Ken¹,Furukawa Yasushi¹,Morita Shuhei¹,Yamamoto Yuki²,Yamashita Shimpei³,Katsuda Masahiro⁴,Hayata Atsushi⁵,Akamatsu Hiroaki⁵^ORCID,Jinnin Masatoshi²,Hara Isao³^ORCID,Yamaue Hiroki⁴,Akamizu Takashi¹

Affiliation:

1. The First Department of Medicine Wakayama Medical University Wakayama Japan

2. Department of Dermatology Wakayama Medical University Wakayama Japan

3. Department of Urology Wakayama Medical University Wakayama Japan

4. Second Department of Surgery Wakayama Medical University Wakayama Japan

5. Department of Respiratory Medicine and Clinical Oncology Wakayama Medical University Wakayama Japan

Funder

Takeda Science Foundation

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.14363

Reference27 articles.

1. Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group

2. Therapeutic use of anti-CTLA-4 antibodies

3. PD-1 and PD-1 ligands: from discovery to clinical application

4. Endocrine dysfunctions during treatment of immune‐checkpoint inhibitors. Trends;Inaba H;Immunotherapy,2018

5. Fulminant Type 1 Diabetes Mellitus Accompanied by Positive Conversion of Anti-insulin Antibody after the Administration of Anti-CTLA-4 Antibody Following the Discontinuation of Anti-PD-1 Antibody

Cited by 103 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Endocrine toxicity of cancer immunotherapy;International Journal of Molecular and Immuno Oncology;2024-08-31

2. Biomarkers associated with immune-related adverse events induced by immune checkpoint inhibitors;World Journal of Clinical Oncology;2024-08-24

3. Cardiovascular toxicities of immune therapies for cancer – a scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Council of Cardio‐Oncology;European Journal of Heart Failure;2024-08

4. Immune landscape of hepatocellular carcinoma: From dysregulation of the immune responses to the potential immunotherapies;Cell Biochemistry and Function;2024-07

5. Secondary adrenocortical insufficiency after treatment with retifanlimab: a case report;Frontiers in Immunology;2024-06-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3